The World Health Organization (WHO) has selected the Institute of Virology at Charité – Universitätsmedizin Berlin as a member of the newly established WHO Coronavirus Network (CoViNet). The global network of reference laboratories aims to detect and…
ProBioGen, a globally recognized and experienced Contract Development & Manufacturing Organization (CDMO), proudly announces a partnership with DIOSynVax Ltd to manufacture DIOS-HFVac3, a trivalent hemorrhagic fever (HF) vaccine that was developed in…
Eckert & Ziegler BEBIG GmbH, subsidiary of Eckert & Ziegler SE with focus on brachytherapy solutions for the treatment of prostate cancer as well as eye and brain tumors, obtained the MDR certificate for its proprietary prostate seeds from DEKRA…
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development, further strengthening Bayer’s precision oncology development portfolio
Co-development of a novel target…
The app-based platform Mika, a provider of digital therapeutics (DTx) for all types of cancer, was selected as one of 16 members for the inaugural cohort of the 2024 CancerX Accelerator program supported by the White House.
Mika was chosen from more…
greenCHEM developing the chemical industry of the future
BIOTRONIK Launches Its Complete Conduction System Pacing (CSP) Solution Consisting of the World’s First Approved CSP System Alongside Comprehensive Training and Expert Support
ProBioGen, a leading CDMO of innovative solutions and services for biopharmaceutical development, is pleased to announce the execution of services and license agreements with MAPP BIOPHARMACEUTICAL, INC. to develop a cell line for an afucosylated…
A research team led by biochemist Professor Helge Ewers from Freie Universität Berlin has developed a new technique for the light-mediated release and investigation of proteins in live cells. The technique makes use of a laser pulse to control the…
Application deadline: April 3
